Abu Dhabi: Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, and Digipharm, a UK-based innovative healthcare solutions provider, have signed a Memorandum of Understanding (MoU) to create and validate a new model for patient care in the UAE. The partnership further seeks to provide the best advanced health technologies and create an enhanced end-to-end patient experience.
The new platform will initially focus on the Bone Marrow Transplantation program and later expand to other specialties at the hospital.
According to the MoU, BMC and Digipharm, which has clients such as the UK National Health Service, will work closely together to implement digitally enabled Value-based Healthcare (VBHC) and Value-based Procurement (VBP) provisions. Mr. John Sunil, CEO of Burjeel Holdings, and Mr. Ahmed Abdulla, CEO of Digipharm, signed the MoU.
At Burjeel Holdings, we firmly believe that technology is a game-changer for advancing healthcare delivery. By leveraging cutting-edge technology, we aim to enhance the patient experience, improve outcomes, and drive innovation in healthcare. We are excited to explore how the new technology can be used to improve Bone Marrow Transplant outcomes. Such collaborations will also bolster the UAE’s transformation journey into a global leader in healthcare.
Mr. Sunil shared.
Mr. Abdulla commented that “we are proud to collaborate with one of the UAE’s largest private healthcare providers. Our platform will optimize the patient journey by identifying gaps and potential risks to deliver better outcomes. This collaboration will also allow us as a solution provider to validate our delivery models in host institutions and patient populations outside of the UK and Europe in a country that is leading digital transformation in the region.”
BMC’s Bone Marrow Transplantation Program, established in 2022, has completed 78 transplant procedures, including 30 in the pediatric population. The new system will help BMC identify the pain points a patient faces during the journey and estimate the associated cost at each step. In addition, it helps in designing solutions and identifying opportunities to reduce the cost of care provision.